AR090307A1 - Polimeros cationicos a base de glucogeno - Google Patents
Polimeros cationicos a base de glucogenoInfo
- Publication number
- AR090307A1 AR090307A1 ARP130100787A ARP130100787A AR090307A1 AR 090307 A1 AR090307 A1 AR 090307A1 AR P130100787 A ARP130100787 A AR P130100787A AR P130100787 A ARP130100787 A AR P130100787A AR 090307 A1 AR090307 A1 AR 090307A1
- Authority
- AR
- Argentina
- Prior art keywords
- glucogen
- cationic polymers
- based cationic
- complexes
- cationic
- Prior art date
Links
- 229920006317 cationic polymer Polymers 0.000 title abstract 2
- 150000001449 anionic compounds Chemical class 0.000 abstract 2
- 229920002527 Glycogen Polymers 0.000 abstract 1
- 125000002091 cationic group Chemical group 0.000 abstract 1
- 229940096919 glycogen Drugs 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/18—Reserve carbohydrates, e.g. glycogen, inulin, laminarin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12159710 | 2012-03-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR090307A1 true AR090307A1 (es) | 2014-11-05 |
Family
ID=47739282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130100787A AR090307A1 (es) | 2012-03-15 | 2013-03-12 | Polimeros cationicos a base de glucogeno |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US9717801B2 (https=) |
| EP (1) | EP2825565B1 (https=) |
| JP (1) | JP6247234B2 (https=) |
| KR (1) | KR101997018B1 (https=) |
| CN (2) | CN104080812B (https=) |
| AR (1) | AR090307A1 (https=) |
| AU (1) | AU2013231561B2 (https=) |
| BR (1) | BR112014018617A8 (https=) |
| CA (1) | CA2859273C (https=) |
| CY (1) | CY1121829T1 (https=) |
| DK (1) | DK2825565T3 (https=) |
| EA (1) | EA032479B1 (https=) |
| ES (1) | ES2732216T3 (https=) |
| GE (1) | GEP201606581B (https=) |
| HR (1) | HRP20191114T1 (https=) |
| HU (1) | HUE045049T2 (https=) |
| IL (1) | IL233823B (https=) |
| LT (1) | LT2825565T (https=) |
| ME (1) | ME03429B (https=) |
| MX (1) | MX351599B (https=) |
| PL (1) | PL2825565T3 (https=) |
| PT (1) | PT2825565T (https=) |
| RS (1) | RS58985B1 (https=) |
| SG (2) | SG11201403816YA (https=) |
| SI (1) | SI2825565T1 (https=) |
| SM (1) | SMT201900342T1 (https=) |
| TR (1) | TR201909387T4 (https=) |
| UA (1) | UA115135C2 (https=) |
| WO (1) | WO2013135471A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR095937A1 (es) | 2013-04-05 | 2015-11-25 | Acraf | Potenciador de la solubilidad en agua a base de glucógeno |
| BR112015027134A8 (pt) | 2013-04-26 | 2019-12-24 | Mirexus Biotechnologies Inc | método e aditivo para mudar o comportamento reológico de uma formulação à base de água ou à base de álcool, composição e método para estabilizar uma formulação ou aumentar a fotoestabilidade de compostos orgânicos |
| BR112017014090A2 (pt) * | 2014-12-29 | 2018-03-06 | Bonac Corporation | composição, e, métodos para produção de uma composição e estabilização de uma molécula de ácido nucleico. |
| CN104558246B (zh) * | 2015-01-20 | 2017-03-01 | 武汉理工大学 | 一种叶酸/生物素修饰的壳聚糖材料及其制备方法 |
| DE102015205088C5 (de) * | 2015-03-20 | 2024-09-26 | Kuka Deutschland Gmbh | Verfahren zum Ermitteln eines Kalibrierungsparameters eines Fahrzeuges sowie Fahrzeug hierzu |
| JP6872782B2 (ja) * | 2016-03-08 | 2021-05-19 | 国立大学法人京都大学 | カチオン性グルカンナノスフェア、複合体、核酸導入剤及びがん治療剤 |
| CN109310644A (zh) * | 2016-04-14 | 2019-02-05 | 奇迹连结生物技术公司 | 包含植物糖原纳米颗粒的抗感染组合物 |
| BR112018072452A2 (pt) * | 2016-05-04 | 2019-02-19 | Mirexus Biotechnologies Inc. | nanopartículas de glicogênio e fitoglicogênio como compostos imunossupressores, e composições e métodos para uso dos mesmos |
| CN105949344B (zh) * | 2016-05-13 | 2019-05-17 | 中山大学 | 一种阳离子超支化多糖衍生物及其在增强血卟啉类光敏剂对肿瘤细胞光毒性方面的应用 |
| WO2019027999A1 (en) * | 2017-07-31 | 2019-02-07 | Ohio State Innovation Foundation | BIOMIMETIC NANOMATERIALS AND USES THEREOF |
| US11384161B2 (en) | 2018-01-11 | 2022-07-12 | Virginia Tech Intellectual Properties, Inc. | Amphiphilic polysaccharides, polysaccharide-based hydrogels, and methods of manufacture |
| CN116178587B (zh) * | 2023-02-28 | 2025-04-11 | 江南大学 | 一种季铵盐化糖原、复合抗菌水凝胶及其制备方法与应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8904370D0 (en) | 1989-02-25 | 1989-04-12 | Cosmas Damian Ltd | Liquid delivery compositions |
| IT1255488B (it) | 1992-08-04 | 1995-11-06 | Angelini Francesco Ist Ricerca | Polisaccaridi del glicogeno |
| US7144713B1 (en) | 1995-10-02 | 2006-12-05 | Emd Biosciences, Inc. | Method for precipitating nucleic acid with visible carrier |
| GB9600272D0 (en) | 1996-01-06 | 1996-03-06 | Univ Nottingham | Polymers |
| US6106858A (en) * | 1997-09-08 | 2000-08-22 | Skyepharma, Inc. | Modulation of drug loading in multivescular liposomes |
| EP1399189A1 (en) | 2001-06-11 | 2004-03-24 | Universite De Montreal | Compositions and methods for enhancing nucleic acid transfer into cells |
| US20030147958A1 (en) | 2002-01-29 | 2003-08-07 | Cheol-Hee Ahn | Biodegradable multi-block copolymers of poly(amino acid)s and poly(ethylene glycol) for the delivery of bioactive agents |
| US20030186916A1 (en) | 2002-03-12 | 2003-10-02 | Lei Yu | Vector for transfection of eukaryotic cells |
| JPWO2005094894A1 (ja) | 2004-03-31 | 2008-02-14 | 株式会社メドジェル | 細胞に核酸を導入するための製剤 |
| WO2007038769A1 (en) | 2005-09-28 | 2007-04-05 | Hetzel Adrian H | Electro-hydraulic timed angle controlled joint simulation torque calibration, certification and analysis device |
| UA97559C2 (uk) | 2007-11-08 | 2012-02-27 | Оцука Фармасьютікал Ко., Лтд. | Комплекс нуклеїнової кислоти і композиція для доставки нуклеїнової кислоти |
| CN101235098A (zh) * | 2008-01-09 | 2008-08-06 | 浙江大学 | 功能性植物多糖的修饰方法 |
| ES2393529T3 (es) * | 2008-12-22 | 2012-12-26 | Unilever Nv | Composiciones de lavandería |
| ES2398430T3 (es) * | 2008-12-22 | 2013-03-19 | Unilever Nv | Composiciones para el lavado de ropa |
| EP2428578B1 (en) * | 2009-05-08 | 2016-03-23 | Ezaki Glico Co., Ltd. | Glucuronic acid-containing glucan, process for production of same, and use of same |
| EP2275085A1 (en) * | 2009-07-07 | 2011-01-19 | University of Rostock | Biodegradable copolymer suitable for delivering nucleic acid materials into cells |
| CN102068698A (zh) * | 2009-11-24 | 2011-05-25 | 深圳先进技术研究院 | 纳米疫苗及其制备方法 |
-
2013
- 2013-02-21 LT LTEP13704973.0T patent/LT2825565T/lt unknown
- 2013-02-21 ME MEP-2019-189A patent/ME03429B/me unknown
- 2013-02-21 UA UAA201406638A patent/UA115135C2/uk unknown
- 2013-02-21 SI SI201331501T patent/SI2825565T1/sl unknown
- 2013-02-21 WO PCT/EP2013/053422 patent/WO2013135471A1/en not_active Ceased
- 2013-02-21 EP EP13704973.0A patent/EP2825565B1/en active Active
- 2013-02-21 CN CN201380007182.9A patent/CN104080812B/zh not_active Expired - Fee Related
- 2013-02-21 KR KR1020147021215A patent/KR101997018B1/ko not_active Expired - Fee Related
- 2013-02-21 TR TR2019/09387T patent/TR201909387T4/tr unknown
- 2013-02-21 CN CN201710472160.XA patent/CN107236052B/zh not_active Expired - Fee Related
- 2013-02-21 HU HUE13704973A patent/HUE045049T2/hu unknown
- 2013-02-21 SM SM20190342T patent/SMT201900342T1/it unknown
- 2013-02-21 BR BR112014018617A patent/BR112014018617A8/pt active Search and Examination
- 2013-02-21 MX MX2014010698A patent/MX351599B/es active IP Right Grant
- 2013-02-21 PT PT13704973T patent/PT2825565T/pt unknown
- 2013-02-21 CA CA2859273A patent/CA2859273C/en not_active Expired - Fee Related
- 2013-02-21 SG SG11201403816YA patent/SG11201403816YA/en unknown
- 2013-02-21 EA EA201491613A patent/EA032479B1/ru not_active IP Right Cessation
- 2013-02-21 AU AU2013231561A patent/AU2013231561B2/en not_active Ceased
- 2013-02-21 GE GEAP201313589A patent/GEP201606581B/en unknown
- 2013-02-21 HR HRP20191114TT patent/HRP20191114T1/hr unknown
- 2013-02-21 PL PL13704973T patent/PL2825565T3/pl unknown
- 2013-02-21 SG SG10201607577QA patent/SG10201607577QA/en unknown
- 2013-02-21 DK DK13704973.0T patent/DK2825565T3/da active
- 2013-02-21 RS RS20190791A patent/RS58985B1/sr unknown
- 2013-02-21 US US14/376,299 patent/US9717801B2/en not_active Expired - Fee Related
- 2013-02-21 JP JP2014561347A patent/JP6247234B2/ja not_active Expired - Fee Related
- 2013-02-21 ES ES13704973T patent/ES2732216T3/es active Active
- 2013-03-12 AR ARP130100787A patent/AR090307A1/es active IP Right Grant
-
2014
- 2014-07-27 IL IL233823A patent/IL233823B/en active IP Right Grant
-
2019
- 2019-06-27 CY CY20191100672T patent/CY1121829T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR090307A1 (es) | Polimeros cationicos a base de glucogeno | |
| BR112014032990A2 (pt) | seringa | |
| UY34566A (es) | 1,4?dihidropirimidinas 4,4?disustituidas y su uso como medicamentos para el tratamiento de la hepatitis b | |
| BR112015011118A2 (pt) | conjugado; composição farmacêutica; e uso de um ou mais dos conjugados | |
| UY35815A (es) | ?locus óptimos del maíz? | |
| CR20150370A (es) | Compuestos antivirales | |
| MX2015002409A (es) | Métodos y composiciones para el tratamiento de una afección genética. | |
| DK2912074T3 (da) | Dermal injicerbar steril sammensætning | |
| BR112017012482A2 (pt) | copolímero estático, composição, uso de um copolímero, e, métodos para liberar um ácido nucleico a uma célula ou tecido alvo e para a produção do copolímero. | |
| GT201200334A (es) | Morfolinopirimidinas y su uso en terapia | |
| MX352245B (es) | Formulacion farmaceutica que comprende una droga biofarmaceutica. | |
| BR112013007362A2 (pt) | composição farmacêutica | |
| MX2016008448A (es) | Conjugados de var2csa-farmaco. | |
| UY34627A (es) | Triterpenoides de c-3 cicloalquenilo con actividad inhibidora de la maduración del vih | |
| DOP2015000060A (es) | Profármacos de aminoquinazolina inhibidora de cinasa | |
| CO6511249A2 (es) | Composiciones que comprenden tramadol y celecoxib en el tratamiento del dolor | |
| BR112014025041B8 (pt) | Composição farmacêutica | |
| UY34730A (es) | Formulaciones farmacéuticas que comprenden antagonistas de ccr3 | |
| CR20150211A (es) | Compuestos diméricos | |
| MX2015012833A (es) | Composiciones antibioticas de ceftolozano. | |
| DOP2014000263A (es) | Métodos de quelatos de oligonucleótidos | |
| MX2017012596A (es) | Una composicion farmaceutica y el uso de la misma. | |
| BR112014030720A8 (pt) | composto, composição farmacêutica e usos de inibidores de fbx03 | |
| MX2014001368A (es) | Soluciones anti-inflamatorias estables para inyección. | |
| BR112015009839A2 (pt) | composição farmacêutica de tapentadol para administração parenteral |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |